Brain Cancer | Topics

 
FDA Grants Fast Track Designation to Berubicin For Treatment of Recurrent Glioblastoma Multiforme
July 05, 2021

Based on its potential to prolong overall survival in patients with glioblastoma multiforme, berubicin was granted fast track designation for the FDA for the treatment of recurrent disease.

Medical World News® Inside the Practice: CancerNetwork® and Albert H. Kim, MD, PhD, on Treating Brain Tumor Malignancies at the Siteman Cancer Center
May 28, 2021

CancerNetwork® spoke with Albert H. Kim, MD, PhD, about a new Brain Tumor Center at Siteman, for which he is the inaugural director.

Clinical Benefit Observed With Dabrafenib Plus Trametinib Combo for Glioma Subtypes
April 15, 2021

A durable clinical benefit was seen from the dual inhibition of the MAPK pathway using BRAF and MEK inhibitors dabrafenib and trametinib, respectively, to treat patients with BRAF V600E mutant low- and high-grade glioma.